Novel biomaterials for bisphosphonate delivery

Biomaterials

Volumn 26, Issue 14, 2005, Pages 2073-2080

  Josse, Solen ^a   Faucheux, Corinne ^a   Soueidan, A ^a   Grimandi, Gaël ^a   Massiot, Dominique ^b   Alonso, Bruno ^b   Janvier, Pascal ^a   Laïb, Samia ^a   Pilet, Paul ^a   Gauthier, Olivier ^a   Daculsi, Guy ^a   Guicheux, Jérôme ^a   Bujoli, Bruno ^a   Bouler, Jean Michel ^a  

^a UNIVERSITÉ DE NANTES   (France)

^b Centre National de la Recherche Scientifique   (France)

Author keywords

Apatite structure; Calcium phosphate; Drug release; Osteoclast

Indexed keywords

ADSORPTION; BONE; CALCIUM COMPOUNDS; CHEMISORPTION; HYDROXYAPATITE; MATHEMATICAL MODELS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHATES;

BIOPHOSPHONATES; CALCIUM PHOSPHATE (CAP); FREUNDLICH EQUATIONS; ZOLEDRONATE SOLUTIONS;

BIOMATERIALS;

BIOMATERIAL; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM PHOSPHATE; CITRATE CALCIUM; HYDROXYAPATITE; ZOLEDRONIC ACID;

ADSORPTION KINETICS; AQUEOUS SOLUTION; ARTICLE; CHEMICAL REACTION; CRYSTAL STRUCTURE; DRUG DELIVERY SYSTEM; DRUG INHIBITION; DRUG RELEASE; OSTEOCLAST; OSTEOLYSIS; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

EID: 20844442278     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2004.05.019     Document Type: Article

References (51)

1. Uhrich K.E., Cannizzaro S.M., Langer R.S., Shakesheff K.M. Polymeric systems for controlled drug release. Chem Rev. 99:1999;3181-3198
2. Ranade V.V. Drug delivery systems 5A. Oral drug delivery. J Clin Pharmacol. 31:1991;2-16
3. Sieminska L., Zerda T.W. Diffusion of steroids from sol-gel glass. J Phys Chem. 100:1996;4591-4597
4. Sieminska L., Ferguson M., Zerda T.W., Couch E.J. Diffusion of steroids in porous sol-gel glass. application in slow drug delivery Sol-gel Sci Technol. 8:1997;1105-1109
5. Böttcher H., Slowik P., Suss W. Sol-gel carrier systems for controlled drug delivery. J Sol-gel Sci Technol. 13:1998;277-281
6. Falaize S., Radin S., Ducheyne P. In vitro behavior of silica-based xerogels intended as controlled release carriers. J Am Ceram Soc. 82:1999;969-976
7. Santos E.M., Radin S., Ducheyne P. Sol-gel derived carrier for the controlled release of proteins. Biomaterials. 20:1999;1695-1700
8. Ahola M., Kortesuo P., Kangasniemi I., Kiesvaara J., Yli-Urpo A. Silica xerogel carrier material for controlled release of toremifene citrate. Int J Pharm. 195:2000;219-227
9. Ahola M., Säilynoja E.S., Raitavuo M.H., Salonen J.I., Yli-Urpo A. In vitro release of heparin from silica xerogels. Biomaterials. 22:2001;2163-2170
10. Otsuka M., Tokumitsu K., Matsuda Y. Solid dosage form preparations from oily medicines and their drug release. Effect of degree of surface-modification of silica gel on the drug release from phytonadione-loaded silica gels. J Control Release. 67:2000;369-384
11. Khan AI, Lei L, Norquist AJ, O'Hare D. Intercalation and controlled release of pharmaceutically active compounds from a layered double hydroxide. Chem Commun 2001;2342-43.
12. Passuti N., Daculsi G., Rogez J.M., Martin S., Bainvel J.V. Macroporous calcium phosphate ceramic performance in human spine fusion. Clin Orthop. 248:1989;169-176
13. Daculsi G., Bagot d'Arc M., Corlieu P., Gersdorff M. Macroporous biphasic calcium phosphate efficiency in mastoid cavity obliteration. experimental and clinical findings Ann Otol Rhinol Laryngol. 101:1992;669-674
14. Piattelli A., Scarano A., Mangano C. Clinical and histologic aspects of biphasic calcium phosphate ceramic (BCP) used in connection with implant placement. Biomaterials. 17:1996;1767-1770
15. Ransford A.O., Morley T., Edgar M.A., Webb P., Passuti N., Chopin D., Morin C., Michel F., Garin C., Pries D. Synthetic porous ceramic compared with autograft in scoliosis surgery. a prospective, randomized study of 341 patients J Bone Joint Surg Br. 80:1998;13-18
16. Cavagna R., Daculsi G., Bouler J.M. Macroporous calcium phosphate ceramic. a prospective study of 106 cases in lumbar spinal fusion J Long Term Eff Med Implants. 9:1999;403-412
17. Delecrin J., Takahashi S., Gouin F., Passuti N. A synthetic porous ceramic as a bone graft substitute in the surgical management of scoliosis. a prospective, randomized study Spine. 25(5):2000;563-569
18. Dorozhkin S.V., Epple M. Biological and medical significance of calcium phosphates. Angew Chem Int Ed. 41:2002;3130-3146
19. Guicheux J., Gauthier O., Aguado E., Heymann D., Pilet P., Couillaud S., Faivre A., Daculsi G. Growth hormone-loaded macroporous calcium phosphate ceramic. in vitro biopharmaceutical characterization and preliminary in vivo study J Biomed Mater Res. 40(4):1998;560-566
20. Obadia L., Amador G., Daculsi G., Bouler J.M. Calcium-deficient apatite. influence of granule size and consolidation mode on release and in vitro activity of vancomycin Biomaterials. 24:2003;1265-1270
21. Slosarczyk A., Szymura-Oleksiak J., Mycek B. The kinetics of pentoxifylline release from drug-loaded hydroxyapatite implants. Biomaterials. 21:2000;1215-1221
22. Netz D.J.A., Sepulveda P., Pandolfelli V.C., Spadaro A.C.C., Alencastre J.B., Bentley M.V.L.B., Marchetti J.M. Potential use of gelcasting hydroxyapatite porous ceramic as an implantable drug delivery system. Int J Pharm. 213:2001;117-125
23. Burgos A.E., Belchior J.C., Sinisterra R.D. Controlled release of rhodium (II) carboxylates and their association complexes with cylcodextrins from hydroxyapatite matrix. Biomaterials. 23:2002;2519-2526
24. Fleich H. In: Bisphosphonates in bone disease, from the laboratory to the patients. 2000;Academic Press, San Francisco
25. Bisphosphonates for osteoporosis. Drug and Therapeutics Bulletin 2001;39:68-72.
26. Doggrell S.A. Zoledronate once-yearly increases bone mineral density - implications for osteoporosis. Expert Opin Pharmacother. 3:2002;1007-1009
27. Denissen H., Van Beek E., Löwik C., Papapoulos S., Van der Hooff A. Ceramic hydroxyapatite implants for the release of bisphosphonate. Bone Min. 25:1994;123-134
28. Denissen H., Van Beek E., Van den Bos T., De Blieck J., Klein C., Van den Hooff A. Degradable bisphosphonate-alkaline phosphatase-complexed hydroxyapatite implants in vitro. J Bone Miner Res. 12:1997;290-297
29. Denissen H., Van Beek E., Martinetti R., Klein C., Van der Zee E., Ravaglioli A. Net-shaped hydroxyapatite implants for release of agents modulating periodontal-like tissues. J Periodont Res. 32:1997;40-46
30. Denissen H., Martinetti R., Van Lingen A., Van den Hooff A. Normal osteoconduction and repair in and around submerged highly bisphosphonate- complexed hydroxyapatite implants in rat tibiae. J Periodont. 71:2000;272-278
31. Denissen H., Montanari C., Martinetti R., Van Lingen A., Van den Hooff A. Alveolar bone response to submerged bisphosphonate-complexed hydroxyapatite implants. J Periodont. 71:2000;279-286
32. LeGeros R.Z. Calcium phosphates in oral biology. Myers H.M. Monographs in oral science. 1991;Karger, Basel
33. Weiss P., Gauthier O., Bouler J.M., Grimandi G., Daculsi G. Injectable bone substitute using a hydrophilic polymer. Bone. 25(Suppl. 2):1999;67S-70S
34. Daculsi G., Weiss P., Bouler J.M., Gauthier O., Millot F., Aguado E. Biphasic calcium phosphate/hydrosoluble polymer composites. a new concept for bone and dental substitution biomaterials Bone. 25(Suppl. 2):1999;59S-61S
35. Gauthier O., Boix D., Grimandi G., Aguado E., Bouler J.M., Weiss P., Daculsi G. A new injectable calcium phosphate biomaterial for immediate bone filling of extraction sockets. a preliminary study in dogs J Periodontol. 70:1999;375-383
36. Gauthier O., Bouler J.M., Weiss P., Bosco J., Daculsi G., Aguado E. Kinetic study of bone ingrowth and ceramic resorption associated with the implantation of different injectable calcium-phosphate bone substitutes. J Biomed Mater Res. 47:1999;28-35
37. Bourgeois B., Laboux O., Gauthier O., Obadia L., Aguado E., Daculsi G., Bouler J.M. Calcium-deficient apatite. a first in vivo study concerning bone ingrowth J Biomed Mater Res. 65A(3):2003;402-408
38. Wilder L., Jaeggi K.A., Glatt M., Müller K., Bachmann R., Bisping M., Born A., Cortesi R., Guiglia G., Jeker H., Klein R., Ramseier U., Schmid J., Schreiber G., Seltenmeyer Y., Green J.R. Highly potent geminal bisphosphonates. From pamidronate (Aredia) to zoledronic acid (Zometa). J Med Chem. 45:2002;3721-3738
39. Ishikawa K., Ducheyne P., Radin S. Determination of the Ca/P ratio in calcium deficient hydroxyapatite using X-ray diffraction analysis. J Mater Sci Mater Med. 4:1993;165-168
40. Ames B.N. Assay of inorganic phosphate, total phosphate and phosphatases. Colowick S.P., Kaplan N.O. Methods in enzymology. Vol. 8:1966;115-118 Academic Press, Orlando
41. Guicheux J., Heymann D., Rousselle A.V., Gouin F., Pilet P., Yamada S., Daculsi G. Growth hormone stimulatory effects on osteoclastic resorption are partly mediated by insulin-like growth factor I. an in vitro study Bone. 22:1998;25-31
42. Schmidt-Rohr KW, Spiess H. In: Harcourt Brace and Company, editors. Multidimensional solid-state NMR and polymers. New York: Academic Press, 1994.
43. Heymann D., Guicheux J., Gouin F., Passuti N., Daculsi G. Cytokines, growth factors and osteoclasts. Cytokine. 10(3):1998;155-168
44. David J.P., Neff L., Chen Y., Rincon M., Horne W.C., Baron R. A new method to isolate large numbers of rabbit osteoclasts and osteoclast-like cells. application to the characterization of serum response element binding proteins during osteoclast differentiation J Bone Miner Res. 13(11):1998;1730-1738
45. Tezuka K., Sato T., Kamioka H., Nijweide P.J., Tanaka K., Matsuo T., Ohta M., Kurihara N., Hakeda Y., Kumegawa M. Identification of osteopontin in isolated rabbit osteoclasts. Biochem Biophys Res Commun. 186(2):1992;911-917
46. Roodman G.D. Advances in bone biology. the osteoclast Endocr Rev. 17(4):1996;308-332
47. Bouler J.M., LeGeros R.Z., Daculsi G. Biphasic calcium phosphates. influence of three synthesis parameters on the HA/beta-TCP ratio J Biomed Mater Res. 51:2000;680-684
48. Freundlich H. In: Hatfield HS, editor. Colloid and capillary chemistry. London: Methuen, 1926.
49. Li E.C., Davis L.E. Zoledronic acid. a new parenteral bisphosphonate Clin Therapeut. 25:2003;2669-2708
50. Reinholz G.G., Getz B., Pederson L., Sanders E.S., Subramaniam M., Ingle J.N., Spelsberg T.C. Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts. Cancer Res. 60:2000;6001-6007
51. Consensus Development Conference, 'Diagnosis, prophylaxis and treatment of osteoporosis', conference report. Am J Med 1993;94(6):646-50.